Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
Titel:
Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
Auteur:
Wehler, Thomas C. Hamdi, Swaantje Maderer, Annett Graf, Claudine Gockel, Ines Schmidtmann, Irene Hainz, Michael Berger, Martin R. Theobald, Matthias Galle, Peter R. Moehler, Markus Schimanski, Carl C.